{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:36:22Z","timestamp":1777404982800,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"N\/A"},{"name":"Project ALS Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accumulating evidence suggests that neuroinflammatory processes are implicated in the initiation and progression of amyotrophic lateral sclerosis (ALS). Previous reports have demonstrated an increase in microgliosis and astrogliosis in the lumbar spinal cord of SOD1<jats:sup><jats:italic>G93A<\/jats:italic><\/jats:sup>transgenic mice before the onset of symptoms, a neuroinflammatory response which correlated with disease progression. Importantly, early stage homeostatic microglia enhanced motor neuron survival, while pro-inflammatory microglia were toxic to motor neurons in the SOD1<jats:sup><jats:italic>G93A<\/jats:italic><\/jats:sup>mice. Recent studies from our group have demonstrated that cromolyn sodium, an FDA approved compound, exerts neuroprotective effects in mouse models of Alzheimer\u2019s disease by altering microglial cell activation. Here, we tested the neuroprotective and anti-inflammatory effects of cromolyn sodium in the SOD1<jats:sup><jats:italic>G93A<\/jats:italic><\/jats:sup>mouse model of ALS. Our results indicate that cromolyn sodium treatment significantly delayed the onset of neurological symptoms, and improved deficits in PaGE performance in both male and female mice, however, there was only an effect on survival in female mice. Furthermore, there was a significant increase in motor neuron survival in the lumbar spinal cord as well as a significant decrease in the denervation of the neuromuscular junction of the tibialis anterior muscle in cromolyn treated transgenic SOD1<jats:sup><jats:italic>G93A<\/jats:italic><\/jats:sup>mice. Lastly, cromolyn treatment decreased the expression of pro-inflammatory cytokines\/chemokines in the lumbar spinal cord and plasma and decreased mast cell degranulation in the tibialis anterior muscle of transgenic SOD1<jats:sup><jats:italic>G93A<\/jats:italic><\/jats:sup>mice. Together, these findings suggest that cromolyn sodium provides neuroprotection in the SOD1<jats:sup><jats:italic>G93A<\/jats:italic><\/jats:sup>mice by decreasing the inflammatory response.<\/jats:p>","DOI":"10.1038\/s41598-019-53982-w","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T11:02:46Z","timestamp":1574852566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Eric J.","family":"Granucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Griciuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaly A.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra N.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8427-3230","authenticated-orcid":false,"given":"Hoang","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Dios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"McGinty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Elmaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Paganoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merit E.","family":"Cudkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7032-1454","authenticated-orcid":false,"given":"Rudolph E.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaleh","family":"Sadri-Vakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"53982_CR1","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao, W., Beers, D. R. & Appel, S. H. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 8, 888\u2013899 (2013).","journal-title":"J Neuroimmune Pharmacol."},{"key":"53982_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","volume":"12","author":"KG Hooten","year":"2015","unstructured":"Hooten, K. G., Beers, D. R., Zhao, W. & Appel, S. H. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 12, 364\u2013375 (2015).","journal-title":"Neurotherapeutics."},{"key":"53982_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 8, 382\u2013397 (2009).","journal-title":"Lancet Neurol."},{"key":"53982_CR4","first-page":"474","volume":"51","author":"M Menza","year":"2010","unstructured":"Menza, M. et al. The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease. Psychosomatics. 51, 474\u2013479 (2010).","journal-title":"Psychosomatics."},{"key":"53982_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","volume":"49","author":"R Niranjan","year":"2014","unstructured":"Niranjan, R. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes. Mol Neurobiol 49, 28\u201338 (2014).","journal-title":"Mol Neurobiol"},{"key":"53982_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2005.10.016","volume":"31","author":"JS Henkel","year":"2006","unstructured":"Henkel, J. S., Beers, D. R., Siklos, L. & Appel, S. H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci. 31, 427\u2013437 (2006).","journal-title":"Mol Cell Neurosci."},{"key":"53982_CR7","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1073\/pnas.0607423103","volume":"103","author":"DR Beers","year":"2006","unstructured":"Beers, D. R. et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103, 16021\u201316026 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53982_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao, B., Zhao, W., Beers, D. R., Henkel, J. S. & Appel, S. H. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol. 237, 147\u2013152 (2012).","journal-title":"Exp Neurol."},{"key":"53982_CR9","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1074\/jbc.M114.586602","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori, Y. et al. A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid beta in the brain in a transgenic model of Alzheimer disease. J Biol Chem. 290, 1966\u20131978 (2015).","journal-title":"J Biol Chem."},{"key":"53982_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19641-2","volume":"8","author":"C Zhang","year":"2018","unstructured":"Zhang, C. et al. Cromolyn Reduces Levels of the Alzheimer\u2019s Disease-Associated Amyloid beta-Protein by Promoting Microglial Phagocytosis. Sci Rep. 8, 1144 (2018).","journal-title":"Sci Rep."},{"key":"53982_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fncel.2015.00462","volume":"9","author":"A Jeyachandran","year":"2015","unstructured":"Jeyachandran, A., Mertens, B., McKissick, E. A. & Mitchell, C. S. Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression. Front Cell Neurosci. 9, 462 (2015).","journal-title":"Front Cell Neurosci."},{"key":"53982_CR12","first-page":"53257","volume":"104","author":"T Hatzipetros","year":"2015","unstructured":"Hatzipetros, T. et al. A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. J Vis Exp. 104, 53257 (2015).","journal-title":"J Vis Exp."},{"key":"53982_CR13","unstructured":"Leitner M., Menzies S. & Lutz C. Working with ALS mice: Guidelines for preclinical testing & colony management. The Jackson Laboratory, http:\/\/jackson.jax.org\/rs\/444-BUH-304\/images\/Working_with_ALS_Mice.pdf (2009)."},{"key":"53982_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 185, 232\u2013240 (2004).","journal-title":"Exp Neurol."},{"key":"53982_CR15","doi-asserted-by":"publisher","first-page":"e0164103","DOI":"10.1371\/journal.pone.0164103","volume":"11","author":"KE Glajch","year":"2016","unstructured":"Glajch, K. E. et al. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One. 11, e0164103 (2016).","journal-title":"PLoS One."},{"key":"53982_CR16","first-page":"3063","volume":"122","author":"KE Lewis","year":"2014","unstructured":"Lewis, K. E. et al. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase. J. Neuroscience. 122, 3063\u201387 (2014).","journal-title":"J. Neuroscience."},{"key":"53982_CR17","doi-asserted-by":"publisher","first-page":"e39216","DOI":"10.1371\/journal.pone.0039216","volume":"7","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider, J. et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One. 7, e39216 (2012).","journal-title":"PLoS One."},{"key":"53982_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1046\/j.1471-4159.2001.00572.x","volume":"79","author":"C Bendotti","year":"2008","unstructured":"Bendotti, C. et al. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem. 79, 737\u2013746 (2008).","journal-title":"J Neurochem."},{"key":"53982_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/mus.20376","volume":"32","author":"P Baron","year":"2005","unstructured":"Baron, P. et al. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve. 32, 541\u20134 (2005).","journal-title":"Muscle Nerve."},{"key":"53982_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1179\/016164107X229795","volume":"29","author":"T Nagata","year":"2007","unstructured":"Nagata, T. et al. Elevation of MCP-1 and MCP-1\/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurol Res. 29, 772\u2013776 (2007).","journal-title":"Neurol Res."},{"key":"53982_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000314164","volume":"86","author":"Y Yang","year":"2010","unstructured":"Yang, Y. et al. G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology. 86, 1\u20135 (2010).","journal-title":"Pharmacology."},{"key":"53982_CR22","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMra1409760","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides, T. C., Valent, P. & Akin, C. Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med. 373, 1885\u20131886 (2015).","journal-title":"N Engl J Med."},{"key":"53982_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00414-w","volume":"8","author":"RJ Lohman","year":"2017","unstructured":"Lohman, R. J. et al. Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nat Commun. 8, 351 (2017).","journal-title":"Nat Commun."},{"key":"53982_CR24","doi-asserted-by":"crossref","unstructured":"Zhang A. et al. Mast cell stabilization alleviates acute lung injury after orthotopic autologous liver transplantation in rats by downregulating inflammation. PLoS One. 8, e75262 (2013).Han H. et al. Autophagy-linked FYVE protein (Alfy) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). In Vitro Cell Dev Biol Anim. 51, 249-63 (2015).","DOI":"10.1371\/journal.pone.0075262"},{"key":"53982_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11626-014-9832-4","volume":"51","author":"H Han","year":"2015","unstructured":"Han, H. et al. Autophagy-linked FYVE protein (Alfy) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). In Vitro Cell Dev Biol Anim. 51, 249\u201363 (2015).","journal-title":"In Vitro Cell Dev Biol Anim."},{"key":"53982_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"53982_CR27","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1046\/j.1460-9568.2002.02287.x","volume":"16","author":"KG H\u00e4usler","year":"2002","unstructured":"H\u00e4usler, K. G. et al. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur J Neurosci. 16, 2113\u20132122 (2002).","journal-title":"Eur J Neurosci."},{"key":"53982_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs, Y. & Steller, H. Programmed cell death in animal development and disease. Cell. 147, 742\u2013758 (2011).","journal-title":"Cell."},{"key":"53982_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15867-8","volume":"7","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. Chemokines protect vascular smooth muscle cells from cell death induced by cyclic mechanical stretch. Sci Rep. 7, 16128 (2017).","journal-title":"Sci Rep."},{"key":"53982_CR30","doi-asserted-by":"publisher","first-page":"e0165290","DOI":"10.1371\/journal.pone.0165290","volume":"11","author":"YH Won","year":"2016","unstructured":"Won, Y. H. et al. Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis. PLoS One. 11, e0165290 (2016).","journal-title":"PLoS One."},{"key":"53982_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuint.2013.04.007","volume":"63","author":"JV Welser-Alves","year":"2013","unstructured":"Welser-Alves, J. V. & Milner, R. Microglia are the major source of TNF-alpha and TGF-beta1 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide, and vitronectin. Neurochem Int. 63, 47\u201353 (2013).","journal-title":"Neurochem Int."},{"key":"53982_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.mcn.2010.09.001","volume":"46","author":"L Tolosa","year":"2011","unstructured":"Tolosa, L., Caraballo-Miralles, V., Olmos, G. & Llad\u00f3, J. TNF-alpha potentiates glutamate-induced spinal cord motoneuron death via NF-kappaB. Mol Cell Neurosci. 46, 176\u2013186 (2011).","journal-title":"Mol Cell Neurosci."},{"key":"53982_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.expneurol.2012.08.004","volume":"238","author":"HZ Yin","year":"2012","unstructured":"Yin, H. Z. et al. TNF-\u03b1 triggers rapid membrane insertion of Ca2+ permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury. Exp Neurol. 238, 93\u2013102 (2012).","journal-title":"Exp Neurol."},{"key":"53982_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu, Y. et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep. 7, 9094 (2017).","journal-title":"Sci Rep."},{"key":"53982_CR35","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller, J., Chalaris, A., Schmidt-Arras, D. & Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 1813, 878\u2013888 (2011).","journal-title":"Biochim Biophys Acta."},{"key":"53982_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip, W. K. E., Hoshi, N., Shouval, D. S., Snapper, S. & Medzhitov, R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 356, 513\u2013519 (2017).","journal-title":"Science."},{"key":"53982_CR37","doi-asserted-by":"publisher","first-page":"e123249","DOI":"10.1172\/jci.insight.123249","volume":"3","author":"E Trias","year":"2017","unstructured":"Trias, E. et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 3, e123249 (2017).","journal-title":"JCI Insight."},{"key":"53982_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0022-510X(95)00255-Z","volume":"135","author":"JR Gorospe","year":"1996","unstructured":"Gorospe, J. R., Nishikawa, B. K. & Hoffman, E. P. Recruitment of mast cells to muscle after mild damage. J Neurol Sci. 135, 10\u201317 (1996).","journal-title":"J Neurol Sci."},{"key":"53982_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14660820410020286","volume":"5","author":"MC Graves","year":"2004","unstructured":"Graves, M. C. et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 5, 213\u2013219 (2004).","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"53982_CR40","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264, 1772\u20131775 (1994).","journal-title":"Science."},{"key":"53982_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","volume":"230","author":"KE Glajch","year":"2012","unstructured":"Glajch, K. E., Fleming, S. M., Surmeier, D. J. & Osten, P. Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson\u2019s disease. Behav Brain Res. 230, 309\u2013316 (2012).","journal-title":"Behav Brain Res."},{"key":"53982_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/exnr.2002.8021","volume":"178","author":"JL Tillerson","year":"2002","unstructured":"Tillerson, J. L., Caudle, W. M., Rever\u00f3n, M. E. & Miller, G. W. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol. 178, 80\u201390 (2002).","journal-title":"Exp Neurol."},{"key":"53982_CR43","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/01.wnr.0000073685.00308.89","volume":"14","author":"P Weydt","year":"2003","unstructured":"Weydt, P., Hong, S. Y., Kliot, M. & M\u00f6ller, T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport. 14, 1051\u20131054 (2003).","journal-title":"Neuroreport."},{"key":"53982_CR44","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1097\/00001756-199709080-00012","volume":"8","author":"P Barn\u00e9oud","year":"1997","unstructured":"Barn\u00e9oud, P., Lolivier, J., Sanger, D. J., Scatton, B. & Moser, P. Quantitative motor assessment in FALS mice: a longitudinal study. Neuroreport. 8, 2861\u20135 (1997).","journal-title":"Neuroreport."},{"key":"53982_CR45","doi-asserted-by":"crossref","unstructured":"Crawley, J. N. What\u2019s Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice, 2nd Edition. 72\u201373 (Wiley-Interscience, 2007).","DOI":"10.1002\/0470119055"},{"key":"53982_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/ng1196-348","volume":"14","author":"K Sango","year":"1996","unstructured":"Sango, K. et al. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet. 14, 348\u2013352 (1996).","journal-title":"Nat Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53982-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53982-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53982-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:15:58Z","timestamp":1695467758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53982-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53982"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53982-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"David Elmaleh is the Scientific Founder and Chairman of AZTherapies and provided cromolyn sodium for our studies. In addition, Rudolph Tanzi is the chairman of the Scientific Advisory Board at AZTherapies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17728"}}